ESC 2026 Heart Failure Treatment Guideline Recommends Finerenone for HFpEF with Level IA
by dr. Nugroho Nitiyoso, MBA
| 11 September 2026
Heart failure is a clinical syndrome resulting from structural or functional impairment of ventricular filling or ejection of blood, which leaves the heart unable to pump sufficient blood to meet the metabolic demands of the body. This progressive condition carries a great global burden, affecting an estimated 64 million individuals worldwide and standing as one of the leading causes of morbidity and mortality, particularly as populations age and survive other cardiovascular events.